NO20070141L - Sma molekyler for behandling av hyperkolesterolemi og relaterte sykdommer - Google Patents

Sma molekyler for behandling av hyperkolesterolemi og relaterte sykdommer

Info

Publication number
NO20070141L
NO20070141L NO20070141A NO20070141A NO20070141L NO 20070141 L NO20070141 L NO 20070141L NO 20070141 A NO20070141 A NO 20070141A NO 20070141 A NO20070141 A NO 20070141A NO 20070141 L NO20070141 L NO 20070141L
Authority
NO
Norway
Prior art keywords
hypercholesterolemia
treatment
molecules
related diseases
atherosclerosis
Prior art date
Application number
NO20070141A
Other languages
English (en)
Norwegian (no)
Inventor
Jagadish C Sircar
Kashinatham Alisala
Richard J Thomas
Haripada Khatuya
Igor Nikoulin
Victor Charles Vassar
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34978959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070141(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of NO20070141L publication Critical patent/NO20070141L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
NO20070141A 2004-06-09 2007-01-08 Sma molekyler for behandling av hyperkolesterolemi og relaterte sykdommer NO20070141L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57822804P 2004-06-09 2004-06-09
PCT/US2005/020661 WO2005123700A1 (en) 2004-06-09 2005-06-09 Small molecules for treatment of hypercholesterolemia and related diseases

Publications (1)

Publication Number Publication Date
NO20070141L true NO20070141L (no) 2007-03-02

Family

ID=34978959

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070141A NO20070141L (no) 2004-06-09 2007-01-08 Sma molekyler for behandling av hyperkolesterolemi og relaterte sykdommer

Country Status (17)

Country Link
US (1) US20050277690A1 (ru)
EP (1) EP1753733A1 (ru)
JP (1) JP2008502737A (ru)
KR (1) KR20070043711A (ru)
CN (1) CN1964955A (ru)
AR (1) AR049217A1 (ru)
AU (1) AU2005255012A1 (ru)
BR (1) BRPI0511871A (ru)
CA (1) CA2568539A1 (ru)
IL (1) IL179209A0 (ru)
MX (1) MXJL06000070A (ru)
NO (1) NO20070141L (ru)
PE (1) PE20060102A1 (ru)
RU (1) RU2006146479A (ru)
TW (1) TW200603794A (ru)
UY (1) UY28951A1 (ru)
WO (1) WO2005123700A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509228A (ja) * 2004-06-09 2008-03-27 アバニール・ファーマシューティカルズ 高コレステロール血症の治療のための逆コレステロール輸送のメディエイタ
CN106916086A (zh) * 2015-12-28 2017-07-04 深圳翰宇药业股份有限公司 一种对硝基苯胺修饰多肽c端的固相合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930024A (en) * 1969-09-02 1975-12-30 Parke Davis & Co Pharmaceutical compositions and methods
US3773946A (en) * 1969-09-02 1973-11-20 Parke Davis & Co Triglyceride-lowering compositions and methods
US4448785A (en) * 1978-01-09 1984-05-15 Sandoz, Inc. N-Unsaturated fatty acid amides of tryptophan ester homologues and anti-cholesteric use thereof
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
IL64542A0 (en) * 1981-12-15 1982-03-31 Yissum Res Dev Co Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
JPS60136512A (ja) * 1983-12-26 1985-07-20 Eisai Co Ltd 脂質代謝改善剤
US4643988A (en) * 1984-05-15 1987-02-17 Research Corporation Amphipathic peptides
DE3423166A1 (de) * 1984-06-22 1986-01-02 Epis S.A., Zug Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
JPH10316641A (ja) * 1997-03-14 1998-12-02 Sankyo Co Ltd カルボン酸誘導体
WO1999003880A1 (en) * 1997-07-15 1999-01-28 Novo Nordisk A/S Nociceptin analogues
US6004925A (en) * 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
ATE384035T1 (de) * 1999-04-01 2008-02-15 Esperion Therapeutics Inc Ether-verbindungen, zusammensetzungen und ihre verwendung
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
FR2820435B1 (fr) * 2001-02-05 2004-02-27 Genfit S A Procedes d'identification de composes modulant le transport inverse du cholesterol
US7429593B2 (en) * 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
WO2004094471A2 (en) * 2003-04-22 2004-11-04 Avanir Pharmaceuticals Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia

Also Published As

Publication number Publication date
PE20060102A1 (es) 2006-02-09
WO2005123700A1 (en) 2005-12-29
AR049217A1 (es) 2006-07-05
CA2568539A1 (en) 2005-12-29
UY28951A1 (es) 2006-01-31
CN1964955A (zh) 2007-05-16
AU2005255012A1 (en) 2005-12-29
KR20070043711A (ko) 2007-04-25
TW200603794A (en) 2006-02-01
RU2006146479A (ru) 2008-07-20
IL179209A0 (en) 2007-03-08
BRPI0511871A (pt) 2008-01-15
JP2008502737A (ja) 2008-01-31
EP1753733A1 (en) 2007-02-21
US20050277690A1 (en) 2005-12-15
MXJL06000070A (es) 2007-04-10

Similar Documents

Publication Publication Date Title
NO20070139L (no) Heterosykliske derivater for behandling av hyperlipidemi og relaterte sykdommer
NO20055474L (no) Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
WO2007112288A3 (en) Cardiovascular composition and use the same for the treatment of alzheimers disease
NO20072223L (no) Glykogenfosforylaseinhibitor forbindelser med farmsoytiske preparater av disse
WO2006045096A3 (en) Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
NO20081810L (no) Modulatorer av metabolisme og behandling av lidelser relatert dertil
NO20070651L (no) Sammensetninger av statiner med bronkodilatorer
WO2006003388A8 (en) Compositions and methods for treating inflammatory disorders
NO20073628L (no) Pyridoner som er nyttige som inhibitorer av kinaser
DK3067057T3 (da) Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
NO20064584L (no) Tetrahydropyridoindolderivater
WO2008115469A3 (en) Role of hedgehog signaling in atherosclerosis and cardiovascular disease
NO20075731L (no) Inhibitorer av mikrosomalt triglyceridtransferprotein og APO-B-sekresjon
WO2007075439A3 (en) Compositions and methods for treating obesity and related metabolic disorders
MY160560A (en) Compositions and methods for treatment of kidney disorders
NO20071510L (no) 4-Amino-substituerte-2-substituerte-1,2,3,4-tetrahydrokinolinforbindelser
NO20076191L (no) Magnesiumsalter av HMG-COA reduktaseinhibitorer
NO20075140L (no) Fremgangsmater og preparater for modulering av vaskulaer integritet
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
NO20100268L (no) Anvendelse av gjaercellevegger til behandling og/eller forebygging av hyperinsulinemi
DK1984014T3 (da) Anvendelse af tpo-peptidforbindelser og farmaceutiske sammensætninger ved behandlingen af anæmi
NO20070141L (no) Sma molekyler for behandling av hyperkolesterolemi og relaterte sykdommer
NO20082838L (no) 9-klor-15-deoksyprostaglandinderivater, fremgangsmate for fremstilling av disse, og anvendelse som medikamenter
NO20070140L (no) Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application